Curative radiotherapy

RADIATION4 trials

Sponsors

MVZ Leopoldina GmbH, Bo Lu, Chengdu Baiyu Pharmaceutical Co., Ltd.

Conditions

Body Weight ChangesBreast CancerLung CancerSolid Tumor, Adult

Phase 1

A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid Tumors

TerminatedNCT06524804

Chengdu Baiyu Pharmaceutical Co., Ltd.Solid Tumor, Adult

Start: 2024-05-15End: 2024-10-18Updated: 2024-12-18

Unknown Phase

Effects of a Paleolithic Lifestyle Intervention in Breast Cancer Patients Undergoing Radiotherapy

CompletedNCT04574323

MVZ Leopoldina GmbHBody Weight Changes, Breast Cancer

Start: 2020-03-19End: 2020-07-16Updated: 2020-12-04

Feasibility and Metabolic Effects of a 5:2 Fasting Intervention in Women With Breast Cancer During Radiotherapy

CompletedNCT05861362

MVZ Leopoldina GmbHBreast Cancer

Start: 2022-06-01End: 2022-11-17Updated: 2023-05-16

Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy

RecruitingNCT06410300

Bo LuLung Cancer

Start: 2024-04-19End: 2030-04-19Target: 125Updated: 2025-06-19

Related Papers

Feasibility and metabolic effects of a 5:2 fasting intervention in women with breast cancer during radiotherapy

Holistic Integrative Oncology2023-10-162 citations